Keyphrases
Natural Killer Cells
100%
Memory-like
87%
DNMT3A
43%
Cell Response
34%
Follicular Lymphoma
32%
Acute Myeloid Leukemia
29%
Cell Differentiation
24%
Chimeric Antigen Receptor T Cells (CAR-T)
22%
Leukemia
22%
Clinical Trials
21%
Subgroup Analysis
21%
DNA Methyltransferase 3a
21%
Human NK Cells
21%
Interleukin-12 (IL-12)
20%
Relapsed or Refractory
19%
Interleukin-15 (IL-15)
19%
Hematopoietic Cell Transplantation
16%
Diffuse Large B-cell Lymphoma (DLBCL)
14%
T Cells
14%
DNMT3A mutation
14%
Hematopoietic Cells
14%
Interleukin-18 (IL-18)
14%
Brentuximab Vedotin
14%
Lymphoma
13%
NK Cell Activity
13%
Antibody-drug Conjugate
13%
Bispecific Antibody
13%
Antibody-antigen
12%
Multiple Myeloma
12%
Donor-derived
11%
Fludarabine
11%
Hematological Malignancies
11%
Relapsed or Refractory Acute Myeloid Leukemia
11%
Antitumor Effect
11%
Haploidentical Hematopoietic Stem Cell Transplantation
11%
Cancer Immunotherapy
11%
Polarity Function
10%
Working Diagnosis
10%
Ultra-deep Sequencing
10%
Melphalan Conditioning
10%
Abnormal Regulation
10%
Recent Advances
10%
Identity Function
10%
Form-Active
10%
Acute Promyelocytic Leukemia
10%
Haploinsufficiency
10%
Eomes
10%
B-cell non-Hodgkin Lymphoma (B-NHL)
10%
Histone Methylation
10%
Filamentary Structure
10%
Medicine and Dentistry
Natural Killer Cell
92%
Clinical Trial
35%
DNA Methyltransferase 3A
32%
Hematopoietic Cell
27%
Acute Myeloid Leukemia
27%
Systematic Review
25%
Cell Differentiation
24%
Natural Killer Cell Response
23%
Subgroup Analysis
21%
Follicular Lymphoma
21%
B Cell
18%
Multiple Myeloma
16%
Cell Transplantation
15%
Oncology
14%
Diffuse Large B-Cell Lymphoma
14%
Interleukin 12
13%
Neoplasm
13%
T Cell
13%
Polatuzumab Vedotin
12%
Antibody-Drug Conjugate
12%
Bispecific Antibody
12%
Hematologic Malignancy
11%
Prevalence
11%
Chimeric Antigen Receptor
11%
Cancer Immunotherapy
11%
Patient with Leukemia
11%
Microtubule
10%
Cell Polarity
10%
Classical Hodgkin Lymphoma
10%
Pediatrics Patient
10%
Non-Hodgkin Lymphoma
10%
Head and Neck Squamous Cell Carcinoma
10%
Head and Neck Cancer
10%
Tumor Differentiation
10%
Histone Demethylation
10%
Acute Promyelocytic Leukemia
10%
Reproducibility
10%
Myeloid Malignancy
10%
Cancer Pathobiology
10%
Tetramer
10%
Granulocyte
10%
Haploinsufficiency
10%
Chimeric Protein
10%
Melanoma
10%
Colorectal Carcinoma
10%
Protein Complex
10%
Cell Activation
10%
CD8 Antigen
10%
Pralatrexate
10%
T-Cell Lymphoma
10%
Immunology and Microbiology
Natural Killer Cell
93%
Hematopoietic Cell
32%
Natural Killer Cell Response
23%
Cell Transplantation
21%
B Cell
17%
Interleukin 12
16%
Multiple Myeloma
16%
T Cell
15%
Cytokine
14%
Whole Exome Sequencing
13%
RNA Sequence
13%
Cell Differentiation
13%
Conditioning
12%
Myeloid
12%
Cell Activation
11%
Chimeric Antigen Receptor
11%
Cancer Immunotherapy
11%
Reed Sternberg Cell
10%
DNA Template
10%
Electron Microscopy
10%
Cyclophosphamide
10%
Brain Tissue
10%
Neck
10%
Haploinsufficiency
10%
CD8
10%
Protein Complex
10%
Neoantigen
10%
Tumor Vaccine
10%
Smoldering Multiple Myeloma
10%
Squamous Cell
8%
Interleukin 15
7%
Exome
7%
Single Nucleotide Polymorphism
7%
Cytotoxicity
6%
Cetuximab
5%
Overall Survival
5%
Interleukin 18
5%
Immunotherapy
5%
